Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Mol Cancer Res. 2019 Jan 16;17(4):860–869. doi: 10.1158/1541-7786.MCR-18-0956

TABLE 2:

DSRG candidates subjected to secondary validation

Gene Targets Human
Module
Fold increase in
proliferation at d7
P value
MAPK14 -- 2.4 +/− 0.4 <0.001
HBP1 1 1.8 +/− 0.16 <0.01
WNT3 1 2.9 +/− 0.4 <0.001
NES 1 0.9 +/− 0.2 N.S.
BHLHE41 1 2.2 +/− 0.2 <0.001
TIAL1 2 1.1 +/− 0.2 N.S.
HTATIP2 2 1.06 +/− 0.032 N.S.
DOLK 2 1.04 +/− 0.06 N.S.